Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Diabetes Obesity and Metabolism

The protective role of TIGIT+ B cells in attenuating type 1 diabetes progression

View Full Paper
Ask AI
Bookmark
Share

Authors

YPYiman PengCentral South UniversityJLJingyue LiChinese Academy of Medical Sciences & Peking Union Medical CollegeYDYing DengFirst Affiliated Hospital of Guangzhou Medical University

Discussion

Loading...

Member takes

Overview

This study demonstrates the protective effects of TIGIT+ B cells in type 1 diabetes, highlighting their role in immune response.

Key Points

  • TIGIT+ B cells' frequency decreases with type 1 diabetes progression, indicating a protective role.
  • In vitro studies showed that TIGIT+ B cells suppress pro-inflammatory T cell functions effectively.
  • Adoptive transfer of TIGIT+ B cells can prevent disease onset in a mouse model of type 1 diabetes.
  • Targeting TIGIT+ B cells represents a promising immunotherapy strategy for type 1 diabetes.

Cite This Study

Peng et al. (2025) studied this question.

synapsesocial.com/papers/68c192579b7b07f3a0616f1chttps://doi.org/10.1111/dom.70092
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1TIGIT acts as an immune checkpoint upon inhibition of PD1 signaling in autoimmune diabetes2024 · 10 citations
  2. 2Reduced TIGIT Expression on T Cells Links Hyperglycemia to Immune Dysregulation in Type 1 Diabetes2026
  3. 3Study of T cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains Marker in Iraqi Patients with DM Type-12025
  4. 4B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes2025
  5. 5B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes2025